Cargando…

Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore

Detalles Bibliográficos
Autores principales:	Tan, Celine Y., Chiew, Calvin J., Lee, Vernon J., Ong, Benjamin, Lye, David Chien, Tan, Kelvin Bryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716291/ https://www.ncbi.nlm.nih.gov/pubmed/36471699 http://dx.doi.org/10.1016/j.lanwpc.2022.100654

Ejemplares similares

Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
por: Tan, Celine Y, et al.
Publicado: (2023)

Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study
por: Tan, Celine Y., et al.
Publicado: (2023)

Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study
por: Chiew, Calvin J, et al.
Publicado: (2023)

Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore
por: Ng, Oon Tek, et al.
Publicado: (2022)

COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study
por: Tan, Wei Chong, et al.
Publicado: (2023)

Monitoring and Evaluating Progress towards Universal Health Coverage in Singapore
por: Tan, Kelvin Bryan, et al.
Publicado: (2014)

Decreased Influenza Incidence under COVID-19 Control Measures, Singapore
por: Soo, Roy Jiunn Jye, et al.
Publicado: (2020)

A case of imported Monkeypox in Singapore
por: Ng, Oon Tek, et al.
Publicado: (2019)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

COVID-19 outbreak in nursing homes in Singapore
por: Tan, Li Feng, et al.
Publicado: (2021)

Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalisations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5 and XBB transmission
por: Wee, Liang En, et al.
Publicado: (2023)

Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020
por: Ng, Yixiang, et al.
Publicado: (2020)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
por: Pung, Rachael, et al.
Publicado: (2023)

mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants
por: Goh, Orlanda, et al.
Publicado: (2023)

Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
por: Wei, Wycliffe E., et al.
Publicado: (2020)

Implementing an Individual-Centric Discharge Process across Singapore Public Hospitals
por: Ng, Reuben, et al.
Publicado: (2021)

BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study
por: Yung, Chee Fu, et al.
Publicado: (2023)

The Characteristics of Patients Associated With High Caregiver Burden in Parkinson's Disease in Singapore
por: Tan, Mark M. J., et al.
Publicado: (2019)

Effectiveness of Containment Measures Against COVID-19 in Singapore: Implications for Other National Containment Efforts
por: Pung, Rachael, et al.
Publicado: (2020)

Cohort profile: Singapore’s nationally representative Retirement and Health Study with 5 waves over 10 years
por: Ng, Reuben, et al.
Publicado: (2022)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
por: Zuo, Fanglei, et al.
Publicado: (2023)

Responding to COVID-19: how an academic infectious diseases division mobilized in Singapore
por: Archuleta, Sophia, et al.
Publicado: (2020)

Neurology of COVID-19 in Singapore
por: Koh, Jasmine Shimin, et al.
Publicado: (2020)

Chikungunya Outbreak, Singapore, 2008
por: Leo, Yee S., et al.
Publicado: (2009)

Covert COVID-19 and false-positive dengue serology in Singapore
por: Yan, Gabriel, et al.
Publicado: (2020)

Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
por: Pung, Rachael, et al.
Publicado: (2020)

SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients
por: Deng, Yao, et al.
Publicado: (2021)

Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
por: Tay, Matthew Zirui, et al.
Publicado: (2023)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Economic impact of dengue in Singapore from 2010 to 2020 and the cost-effectiveness of Wolbachia interventions
por: Soh, Stacy, et al.
Publicado: (2021)

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
por: Doria-Rose, Nicole, et al.
Publicado: (2021)

Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore
por: Phua, Hwee Pin, et al.
Publicado: (2021)

Surviving the COVID-19 pandemic: early response of a gynecologic oncology unit in Singapore
por: Lim, Yu Hui, et al.
Publicado: (2020)

40-Year Projections of Disability and Social Isolation of Older Adults for Long-Range Policy Planning in Singapore
por: Ng, Reuben, et al.
Publicado: (2020)

Minding the treatment gap: results of the Singapore Mental Health Study
por: Subramaniam, Mythily, et al.
Publicado: (2019)

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
por: Yoon, Sarang K., et al.
Publicado: (2022)

Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Bradley, Todd, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9jq0rt833clkeqr5tg4ggggps9